16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCOHEN, Hannah
dc.contributor.authorCUADRADO, Maria J.
dc.contributor.authorERKAN, Doruk
dc.contributor.authorDUARTE-GARCIA, Ali
dc.contributor.authorISENBERG, David A.
dc.contributor.authorKNIGHT, Jason S.
dc.contributor.authorORTEL, Thomas L.
dc.contributor.authorRAHMAN, Anisur
dc.contributor.authorSALMON, Jane E.
dc.contributor.authorTEKTONIDOU, Maria G.
dc.contributor.authorWILLIAMS, David J.
dc.contributor.authorWILLIS, Rohan
dc.contributor.authorWOLLER, Scott C.
dc.contributor.authorANDRADE, Danieli
dc.date.accessioned2021-06-17T13:57:53Z
dc.date.available2021-06-17T13:57:53Z
dc.date.issued2020
dc.description.abstractAntiphospholipid syndrome (APS), an acquired autoimmune thrombophilia, is characterised by thrombosis and/or pregnancy morbidity in association with persistent antiphospholipid antibodies. The 16th International Congress on Antiphospholipid Antibodies Task Force on APS Treatment Trends reviewed the current status with regard to existing and novel treatment trends for APS, which is the focus of this Task Force report. The report addresses current treatments and developments since the last report, on the use of direct oral anticoagulants in patients with APS, antiplatelet agents, adjunctive therapies (hydroxychloroquine, statins and vitamin D), targeted treatment including rituximab, belimumab, and anti-TNF agents, complement inhibition and drugs based on peptides of beta-2-glycoprotein I. In addition, the report summarises potential new players, including coenzyme Q10, adenosine receptor agonists and adenosine potentiation. In each case, the report provides recommendations for clinicians, based on the current state of the art, and suggests a clinical research agenda. The initiation and development of appropriate clinical studies requires a focus on devising suitable outcome measures, including a disease activity index, an optimal damage index, and a specific quality of life index.eng
dc.description.indexMEDLINEeng
dc.description.sponsorshipMedical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/P017371/1] Funding Source: Medline
dc.identifier.citationLUPUS, v.29, n.12, p.1571-1593, 2020
dc.identifier.doi10.1177/0961203320950461
dc.identifier.eissn1477-0962
dc.identifier.issn0961-2033
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/41009
dc.language.isoeng
dc.publisherSAGE PUBLICATIONS LTDeng
dc.relation.ispartofLupus
dc.rightsopenAccesseng
dc.rights.holderCopyright SAGE PUBLICATIONS LTDeng
dc.subjectAntiphospholipid syndromeeng
dc.subjectdirect oral anticoagulantseng
dc.subjectbiologicseng
dc.subjectcomplement inhibitioneng
dc.subjectanti-&#946eng
dc.subject2-glycoprotein I peptideseng
dc.subjectpotential new playerseng
dc.subject.othersystemic-lupus-erythematosuseng
dc.subject.otherneutrophil extracellular trapseng
dc.subject.otherprimary thrombosis prophylaxiseng
dc.subject.otheracute venous thromboembolismeng
dc.subject.otherdirect oral anticoagulantseng
dc.subject.othervitamin-d deficiencyeng
dc.subject.othertissue factoreng
dc.subject.othercomplement activationeng
dc.subject.otherpregnancy losseng
dc.subject.otherprimary preventioneng
dc.subject.wosRheumatologyeng
dc.title16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trendseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryGrécia
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryisogb
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisogr
hcfmusp.author.externalCOHEN, Hannah:UCL, Haemostasis Res Unit, Dept Haematol, 1st Floor,51 Chenies Mews, London WC1E 6HX, England; Univ Coll London Hosp NHS Fdn Trust, London, England
hcfmusp.author.externalCUADRADO, Maria J.:Clin Univ Navarra, Rheumatol Dept, Madrid, Spain
hcfmusp.author.externalERKAN, Doruk:Weill Cornell Med, Barbara Volcker Ctr Women & Rheumat Dis, Hosp Special Surg, New York, NY USA
hcfmusp.author.externalDUARTE-GARCIA, Ali:Mayo Clin, Div Rheumatol, Dept Internal Med, Rochester, MN USA; Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deli, Rochester, MN USA
hcfmusp.author.externalISENBERG, David A.:Univ Coll London Hosp NHS Fdn Trust, London, England; UCL, Div Med, Ctr Rheumatol, London, England
hcfmusp.author.externalKNIGHT, Jason S.:Univ Michigan, Div Rheumatol, Ann Arbor, MI 48109 USA
hcfmusp.author.externalORTEL, Thomas L.:Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA
hcfmusp.author.externalRAHMAN, Anisur:UCL, Div Med, Ctr Rheumatol, London, England
hcfmusp.author.externalSALMON, Jane E.:Weill Cornell Med, Hosp Special Surg, Div Rheumatol, New York, NY USA
hcfmusp.author.externalTEKTONIDOU, Maria G.:Natl & Kapodistrian Univ Athens, Dept Propaedeut Internal Med 1, Athens, Greece
hcfmusp.author.externalWILLIAMS, David J.:Univ Coll London Hosp NHS Fdn Trust, London, England; UCL, UCL EGA Inst Womens Hlth, London, England
hcfmusp.author.externalWILLIS, Rohan:Univ Texas Med Branch, Antiphospholipid Standardizat Lab, Galveston, TX 77555 USA
hcfmusp.author.externalWOLLER, Scott C.:Intermt Med Ctr, Dept Med, Murray, UT USA; Univ Utah, Sch Med, Div Gen Internal Med, Salt Lake City, UT USA
hcfmusp.citation.scopus74
hcfmusp.contributor.author-fmusphcDANIELI CASTRO OLIVEIRA DE ANDRADE
hcfmusp.description.beginpage1571
hcfmusp.description.endpage1593
hcfmusp.description.issue12
hcfmusp.description.volume29
hcfmusp.origemWOS
hcfmusp.origem.pubmed33100166
hcfmusp.origem.scopus2-s2.0-85094628694
hcfmusp.origem.wosWOS:000584375600009
hcfmusp.publisher.cityLONDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceAakjaer S, 2017, RESPIR MED CASE REP, V22, P263, DOI 10.1016/j.rmcr.2017.09.012eng
hcfmusp.relation.referenceAbalos E, 2013, EUR J OBSTET GYN R B, V170, P1, DOI 10.1016/j.ejogrb.2013.05.005eng
hcfmusp.relation.referenceAbisror N, 2015, PRESSE MED, V44, P100, DOI 10.1016/j.lpm.2014.05.021eng
hcfmusp.relation.referenceAdamson R, 2008, JCR-J CLIN RHEUMATOL, V14, P359, DOI 10.1097/RHU.0b013e31818f38d4eng
hcfmusp.relation.referenceAgmon-Levin N, 2011, ANN RHEUM DIS, V70, P145, DOI 10.1136/ard.2010.134817eng
hcfmusp.relation.referenceAhmed A, 2020, BJOG-INT J OBSTET GY, V127, P478, DOI 10.1111/1471-0528.16013eng
hcfmusp.relation.referenceAli RA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09801-xeng
hcfmusp.relation.referenceAlijotas-Reig J, 2019, SEMIN ARTHRITIS RHEU, V49, P314, DOI 10.1016/j.semarthrit.2019.02.006eng
hcfmusp.relation.referenceAndrade D, 2017, ANTIPHOSPHOLIPID SYN, P317eng
hcfmusp.relation.referenceAndreoli L, 2012, LUPUS, V21, P736, DOI 10.1177/0961203312446386eng
hcfmusp.relation.referenceArachchillage DRJ, 2016, J THROMB HAEMOST, V14, P2177, DOI 10.1111/jth.13475eng
hcfmusp.relation.referenceArnaud L, 2015, AUTOIMMUN REV, V14, P192, DOI 10.1016/j.autrev.2014.10.019eng
hcfmusp.relation.referenceArnaud L, 2014, AUTOIMMUN REV, V13, P281, DOI 10.1016/j.autrev.2013.10.014eng
hcfmusp.relation.referenceBaker KP, 2003, ARTHRITIS RHEUM-US, V48, P3253, DOI 10.1002/art.11299eng
hcfmusp.relation.referenceBakhtar O, 2014, TRANSPLANTATION, V98, pE17, DOI 10.1097/TP.0000000000000267eng
hcfmusp.relation.referenceBateman BT, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1035eng
hcfmusp.relation.referenceBates SM, 2012, CHEST, V141, pE691S, DOI 10.1378/chest.11-2300eng
hcfmusp.relation.referenceBecarevic M, 2017, J THROMB THROMBOLYS, V44, P565, DOI 10.1007/s11239-017-1571-4eng
hcfmusp.relation.referenceBelizna C, 2018, AUTOIMMUN REV, V17, P1153, DOI 10.1016/j.autrev.2018.05.012eng
hcfmusp.relation.referenceBelizna C, 2015, AUTOIMMUN REV, V14, P358, DOI 10.1016/j.autrev.2014.12.006eng
hcfmusp.relation.referenceBeltowski J, 2011, ATHEROSCLEROSIS, V219, P526, DOI 10.1016/j.atherosclerosis.2011.08.009eng
hcfmusp.relation.referenceBerman H, 2013, AUTOIMMUN REV, V12, P1085, DOI 10.1016/j.autrev.2013.05.004eng
hcfmusp.relation.referenceBodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718eng
hcfmusp.relation.referenceBoehringer-Ingelheim, SUMM PROD CHAR PERSeng
hcfmusp.relation.referenceBordin G, 2003, LUPUS, V12, P851, DOI 10.1191/0961203303lu445creng
hcfmusp.relation.referenceBreen KA, 2012, THROMB HAEMOSTASIS, V107, P423, DOI 10.1160/TH11-08-0554eng
hcfmusp.relation.referenceBurcoglu-O'Ral A, 2002, J RHEUMATOL, V29, P2006eng
hcfmusp.relation.referenceCanaud G, 2013, AM J TRANSPLANT, V13, P2179, DOI 10.1111/ajt.12319eng
hcfmusp.relation.referenceCartin-Ceba R, 2014, ARTHRIT CARE RES, V66, P301, DOI 10.1002/acr.22109eng
hcfmusp.relation.referenceCervera R, 2002, ARTHRITIS RHEUM-US, V46, P1019, DOI 10.1002/art.10187eng
hcfmusp.relation.referenceCervera R, 2018, J AUTOIMMUN, V92, P1, DOI 10.1016/j.jaut.2018.05.007eng
hcfmusp.relation.referenceChalam KV, 2007, EUR J OPHTHALMOL, V17, P867eng
hcfmusp.relation.referenceChaturvedi S, 2020, BLOOD, V135, P239, DOI 10.1182/blood.2019003863eng
hcfmusp.relation.referenceChatzidionysiou K, 2020, ANN RHEUM DIS, V79, P304, DOI 10.1136/annrheumdis-2019-216367eng
hcfmusp.relation.referenceCheemalavagu Shashank, 2020, BMJ Case Rep, V13, DOI 10.1136/bcr-2019-232907eng
hcfmusp.relation.referenceCohen H, 2020, J THROMB HAEMOST, V18, P259, DOI 10.1111/jth.14674eng
hcfmusp.relation.referenceCohen H, 2016, LANCET HAEMATOL, V3, pE426, DOI 10.1016/S2352-3026(16)30079-5eng
hcfmusp.relation.referenceCrowther MA, 2003, NEW ENGL J MED, V349, P1133, DOI 10.1056/NEJMoa035241eng
hcfmusp.relation.referenceCuadrado MJ, 2006, J THROMB HAEMOST, V4, P2461, DOI 10.1111/j.1538-7836.2006.02193.xeng
hcfmusp.relation.referenceCuadrado MJ, 1997, ARTHRITIS RHEUM-US, V40, P834, DOI 10.1002/art.1780400509eng
hcfmusp.relation.referencede la Torre YM, 2012, J AUTOIMMUN, V38, pJ209, DOI 10.1016/j.jaut.2011.11.009eng
hcfmusp.relation.referenceDevignes J, 2019, INT J LAB HEMATOL, V41, P726, DOI 10.1111/ijlh.13094eng
hcfmusp.relation.referenceDioszegi A, 2018, LUPUS, V27, P1552, DOI 10.1177/0961203318768890eng
hcfmusp.relation.referenceDlott JS, 2012, CURR RHEUMATOL REP, V14, P71, DOI 10.1007/s11926-011-0227-1eng
hcfmusp.relation.referenceDu HL, 2005, MOL ENDOCRINOL, V19, P2222, DOI 10.1210/me.2004-0336eng
hcfmusp.relation.referenceDuarte-Garca A, 2019, ARTHRITIS RHEUMATOL, V71, P1545, DOI 10.1002/art.40901eng
hcfmusp.relation.referenceDufrost V, 2018, AUTOIMMUN REV, V17, P1011, DOI 10.1016/j.autrev.2018.04.009eng
hcfmusp.relation.referenceEby JC, 2014, INFECT IMMUN, V82, P5256, DOI 10.1128/IAI.02487-14eng
hcfmusp.relation.referenceEmmi G, 2019, AUTOIMMUN REV, V18, P312, DOI 10.1016/j.autrev.2018.11.002eng
hcfmusp.relation.referenceErkan D, 2018, LUPUS, V27, P399, DOI 10.1177/0961203317724219eng
hcfmusp.relation.referenceErkan D, 2007, ARTHRITIS RHEUM-US, V56, P2382, DOI 10.1002/art.22663eng
hcfmusp.relation.referenceErkan D, 2014, ANN RHEUM DIS, V73, P1176, DOI 10.1136/annrheumdis-2013-203622eng
hcfmusp.relation.referenceErkan D, 2014, AUTOIMMUN REV, V13, P685, DOI 10.1016/j.autrev.2014.01.053eng
hcfmusp.relation.referenceErkan D, 2013, ARTHRITIS RHEUM-US, V65, P464, DOI 10.1002/art.37759eng
hcfmusp.relation.referenceEspinola RG, 2002, THROMB HAEMOSTASIS, V87, P518eng
hcfmusp.relation.referenceFanouriakis A, 2019, ANN RHEUM DIS, V78, P736, DOI 10.1136/annrheumdis-2019-215089eng
hcfmusp.relation.referenceFerrara DE, 2004, J THROMB HAEMOST, V2, P1558, DOI 10.1111/j.1538-7836.2004.00896.xeng
hcfmusp.relation.referenceFinazzi G, 2005, J THROMB HAEMOST, V3, P848, DOI 10.1111/j.1538-7836.2005.01340.xeng
hcfmusp.relation.referenceFinazzi G, 2012, LUPUS, V21, P747, DOI 10.1177/0961203312437440eng
hcfmusp.relation.referenceFlessa CM, 2019, CLIN IMMUNOL, V209, DOI 10.1016/j.clim.2019.108265eng
hcfmusp.relation.referenceGambhir V, 2011, IMMUNOBIOLOGY, V216, P988, DOI 10.1016/j.imbio.2011.03.011eng
hcfmusp.relation.referenceGamoudi D, 2017, CLIN CASE REP, V5, P845, DOI 10.1002/ccr3.946eng
hcfmusp.relation.referenceGarcia-Carrasco M, 2018, LUPUS, V27, P2181, DOI 10.1177/0961203318801520eng
hcfmusp.relation.referenceGarrido-Maraver J, 2014, FRONT BIOSCI-LANDMRK, V19, P619, DOI 10.2741/4231eng
hcfmusp.relation.referenceGelber SE, 2015, J IMMUNOL, V195, P1129, DOI 10.4049/jimmunol.1402220eng
hcfmusp.relation.referenceGiannakopoulos B, 2007, BLOOD, V109, P422, DOI 10.1182/blood-2006-04-001206eng
hcfmusp.relation.referenceGirardi G, 2004, NAT MED, V10, P1222, DOI 10.1038/nm1121eng
hcfmusp.relation.referenceGirardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI18817eng
hcfmusp.relation.referenceGirardi G, 2017, J REPROD IMMUNOL, V124, P15, DOI 10.1016/j.jri.2017.09.009eng
hcfmusp.relation.referenceGkogkolou P, 2017, J DERMATOL TREAT, V28, P564, DOI 10.1080/09546634.2017.1282599eng
hcfmusp.relation.referenceGlynn RJ, 2009, NEW ENGL J MED, V360, P1851, DOI 10.1056/NEJMoa0900241eng
hcfmusp.relation.referenceGoldhaber SZ, 2016, VASC MED, V21, P506, DOI 10.1177/1358863X16668588eng
hcfmusp.relation.referenceGrenn RC, 2017, ANN RHEUM DIS, V76, P450, DOI 10.1136/annrheumdis-2016-209442eng
hcfmusp.relation.referenceGris JC, 2012, BLOOD, V119, P2624, DOI 10.1182/blood-2011-09-381913eng
hcfmusp.relation.referenceGualtierotti R, 2018, OPEN RHEUMATOL J, V12, P248, DOI 10.2174/1874312901812010248eng
hcfmusp.relation.referenceGustavsen A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006338eng
hcfmusp.relation.referenceHadaya K, 2011, AM J TRANSPLANT, V11, P2523, DOI 10.1111/j.1600-6143.2011.03696.xeng
hcfmusp.relation.referenceHahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664eng
hcfmusp.relation.referenceHeit JA, 2016, J THROMB THROMBOLYS, V41, P3, DOI 10.1007/s11239-015-1311-6eng
hcfmusp.relation.referenceHelgeson SA, 2018, OXF MED CASE REP, P335, DOI 10.1093/omcr/omy072eng
hcfmusp.relation.referenceHemmati I, 2013, CLIN RHEUMATOL, V32, P1095, DOI 10.1007/s10067-013-2244-0eng
hcfmusp.relation.referenceHennessey A, 2019, BMC RHEUMATOL, V3, DOI 10.1186/s41927-019-0082-7eng
hcfmusp.relation.referenceHillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688eng
hcfmusp.relation.referenceHisada R, 2019, J THROMB HAEMOST, V17, P1134, DOI 10.1111/jth.14427eng
hcfmusp.relation.referenceIoannou Y, 2008, ANN RHEUM DIS, V67, P425, DOI 10.1136/ard.2007.078402eng
hcfmusp.relation.referenceIoannou Y, 2009, J THROMB HAEMOST, V7, P833, DOI 10.1111/j.1538-7836.2009.03316.xeng
hcfmusp.relation.referenceIoannou Y, 2007, ARTHRITIS RHEUM-US, V56, P280, DOI 10.1002/art.22306eng
hcfmusp.relation.referenceKaralis DG, 2016, J CLIN LIPIDOL, V10, P1081, DOI 10.1016/j.jacl.2016.07.002eng
hcfmusp.relation.referenceKearon C, 2018, BLOOD, V131, P2151, DOI 10.1182/blood-2017-09-805689eng
hcfmusp.relation.referenceKeeling D, 2011, BRIT J HAEMATOL, V154, P311, DOI 10.1111/j.1365-2141.2011.08753.xeng
hcfmusp.relation.referenceKelly RJ, 2015, NEW ENGL J MED, V373, P1032, DOI 10.1056/NEJMoa1502950eng
hcfmusp.relation.referenceKim MY, 2018, ANN RHEUM DIS, V77, P549, DOI 10.1136/annrheumdis-2017-212224eng
hcfmusp.relation.referenceKim MY, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.09.066eng
hcfmusp.relation.referenceKnight JS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01322eng
hcfmusp.relation.referenceKnight JS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93897eng
hcfmusp.relation.referenceKolyada A, 2016, J THROMB HAEMOST, V14, P1298, DOI 10.1111/jth.13314eng
hcfmusp.relation.referenceKolyada A, 2014, BLOOD, V123, P1090, DOI 10.1182/blood-2013-08-520882eng
hcfmusp.relation.referenceKolyada A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015345eng
hcfmusp.relation.referenceKravvariti E, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102491eng
hcfmusp.relation.referenceKronbichler A, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000143eng
hcfmusp.relation.referenceLaloux P, 2013, CURR VASC PHARMACOL, V11, P812, DOI 10.2174/157016111106140128113121eng
hcfmusp.relation.referenceLaplante P, 2016, LUPUS, V25, P162, DOI 10.1177/0961203315603146eng
hcfmusp.relation.referenceLefkou E, 2016, J CLIN INVEST, V126, P2933, DOI 10.1172/JCI86957eng
hcfmusp.relation.referenceLegault K, 2018, RES PRACT THROMB S1, V2, P204eng
hcfmusp.relation.referenceLockshin MD, 2012, ARTHRITIS RHEUM-US, V64, P2311, DOI 10.1002/art.34402eng
hcfmusp.relation.referenceLonati PA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00773eng
hcfmusp.relation.referenceLonze BE, 2010, NEW ENGL J MED, V362, P1744, DOI 10.1056/NEJMc0910965eng
hcfmusp.relation.referenceMak A, 2010, RHEUMATOLOGY, V49, P281, DOI 10.1093/rheumatology/kep373eng
hcfmusp.relation.referenceMalec K, 2020, LUPUS, V29, P37, DOI 10.1177/0961203319889156eng
hcfmusp.relation.referenceMartinez-Moreno JM, 2016, FASEB J, V30, P1367, DOI 10.1096/fj.15-272872eng
hcfmusp.relation.referenceMcDonnell TCR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02413eng
hcfmusp.relation.referenceMeng H, 2017, ARTHRITIS RHEUMATOL, V69, P655, DOI 10.1002/art.39938eng
hcfmusp.relation.referenceMeroni PL, 2001, ARTHRITIS RHEUM-US, V44, P2870, DOI 10.1002/1529-0131(200112)44:12<2870::AID-ART475>3.0.CO;2-Yeng
hcfmusp.relation.referenceMerrill JT, 2010, ARTHRITIS RHEUM-US, V62, P222, DOI 10.1002/art.27233eng
hcfmusp.relation.referenceMiranda S, 2020, J THROMB HAEMOST, V18, P926, DOI 10.1111/jth.14720eng
hcfmusp.relation.referenceMiyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.xeng
hcfmusp.relation.referenceMorales JM, 2015, J AM SOC NEPHROL, V26, P735, DOI 10.1681/ASN.2014030228eng
hcfmusp.relation.referenceNewland AC, 2020, AM J HEMATOL, V95, P178, DOI 10.1002/ajh.25680eng
hcfmusp.relation.referenceNuri E, 2017, IMMUNOL RES, V65, P17, DOI 10.1007/s12026-016-8812-zeng
hcfmusp.relation.referenceOesterle A, 2017, CIRC RES, V120, P229, DOI 10.1161/CIRCRESAHA.116.308537eng
hcfmusp.relation.referenceOrdi-Ros J, 2019, ANN INTERN MED, V171, P685, DOI 10.7326/M19-0291eng
hcfmusp.relation.referenceOstertag MV, 2006, LUPUS, V15, P358, DOI 10.1191/0961203306lu2315oaeng
hcfmusp.relation.referenceOta K, 2014, HUM REPROD, V29, P208, DOI 10.1093/humrep/det424eng
hcfmusp.relation.referencePengo V, 2013, J THROMB HAEMOST, V11, P1527, DOI 10.1111/jth.12264eng
hcfmusp.relation.referencePengo V, 2018, BLOOD, V132, P1365, DOI 10.1182/blood-2018-04-848333eng
hcfmusp.relation.referencePerez-Sanchez C, 2017, ARTERIOSCL THROM VAS, V37, P1923, DOI 10.1161/ATVBAHA.117.309225eng
hcfmusp.relation.referencePerez-Sanchez C, 2012, BLOOD, V119, P5859, DOI 10.1182/blood-2011-12-400986eng
hcfmusp.relation.referencePharmacovigilance Risk Assessment Committee (PRAC), 2019, EMAPRAC2199852019eng
hcfmusp.relation.referencePiantoni S, 2012, REUMATISMO, V64, P307, DOI 10.4081/reumatismo.2012.307eng
hcfmusp.relation.referencePierangeli SS, 2005, ANN NY ACAD SCI, V1051, P413, DOI 10.1196/annals.1361.083eng
hcfmusp.relation.referencePierangeli SS, 1999, CIRCULATION, V99, P1997, DOI 10.1161/01.CIR.99.15.1997eng
hcfmusp.relation.referenceRadin M, 2017, INT J CARDIOL, V240, P72, DOI 10.1016/j.ijcard.2017.02.155eng
hcfmusp.relation.referenceRadin M, 2019, SEMIN ARTHRITIS RHEU, V49, P464, DOI 10.1016/j.semarthrit.2019.04.009eng
hcfmusp.relation.referenceRamirez GA, 2019, RHEUMATOLOGY, V58, P940, DOI 10.1093/rheumatology/key307eng
hcfmusp.relation.referenceRand JH, 2017, THROMB RES, V156, P119, DOI 10.1016/j.thromres.2017.06.014eng
hcfmusp.relation.referenceRand JH, 2010, BLOOD, V115, P2292, DOI 10.1182/blood-2009-04-213520eng
hcfmusp.relation.referenceRedecha P, 2007, BLOOD, V110, P2423, DOI 10.1182/blood-2007-01-070631eng
hcfmusp.relation.referenceRiancho-Zarrabeitia L, 2018, SEMIN ARTHRITIS RHEU, V47, P877, DOI 10.1016/j.semarthrit.2017.10.007eng
hcfmusp.relation.referenceRitis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794eng
hcfmusp.relation.referenceRovin BH, 2012, ARTHRITIS RHEUM-US, V64, P1215, DOI 10.1002/art.34359eng
hcfmusp.relation.referenceRymarz A, 2018, BMC NEPHROL, V19, DOI 10.1186/s12882-018-0928-zeng
hcfmusp.relation.referenceSalmon JE, 2008, J REPROD IMMUNOL, V77, P51, DOI 10.1016/j.jri.2007.02.007eng
hcfmusp.relation.referenceSalmon JE, 2002, ANN RHEUM DIS, V61, P46eng
hcfmusp.relation.referenceSamudra AN, 2018, J AUTOIMMUN, V88, P131, DOI 10.1016/j.jaut.2017.10.009eng
hcfmusp.relation.referenceSanchez-Redondo J, 2019, CLIN THER, V41, P1839, DOI 10.1016/j.clinthera.2019.06.015eng
hcfmusp.relation.referenceSato T, 2019, LUPUS, V28, P1577, DOI 10.1177/0961203319881200eng
hcfmusp.relation.referenceSchmidt-Tanguy A, 2013, J THROMB HAEMOSTeng
hcfmusp.relation.referenceSchouwers SME, 2010, THROMB RES, V125, P102, DOI 10.1016/j.thromres.2009.09.001eng
hcfmusp.relation.referenceSchreiber K, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/nrdp.2017.103, 10.1038/nrdp.2018.5]eng
hcfmusp.relation.referenceSchreiber K, 2017, SEMIN THROMB HEMOST, V43, P562, DOI 10.1055/s-0037-1603359eng
hcfmusp.relation.referenceSciascia S, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.09.078eng
hcfmusp.relation.referenceSciascia S, 2014, LUPUS, V23, P1286, DOI 10.1177/0961203314541317eng
hcfmusp.relation.referenceSciascia S, 2018, ANN RHEUM DIS, V77, P1693, DOI 10.1136/annrheumdis-2018-213496eng
hcfmusp.relation.referenceSciascia S, 2016, THROMB HAEMOSTASIS, V115, P285, DOI 10.1160/TH15-06-0491eng
hcfmusp.relation.referenceScragg R, 2017, JAMA CARDIOL, V2, P608, DOI 10.1001/jamacardio.2017.0175eng
hcfmusp.relation.referenceShapira I, 2012, ARTHRITIS RHEUM-US, V64, P2719, DOI 10.1002/art.34440eng
hcfmusp.relation.referenceShishikura K, 2016, BRIT J PHARMACOL, V173, P319, DOI 10.1111/bph.13373eng
hcfmusp.relation.referenceSoroka N, 2016, ANN RHEUM DIS, V75, P1048, DOI 10.1136/annrheumdis-2016-eular.4666eng
hcfmusp.relation.referenceStefanovic V, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030407eng
hcfmusp.relation.referenceSTEPHANOU A, 1994, ENDOCRINOLOGY, V135, P2651, DOI 10.1210/en.135.6.2651eng
hcfmusp.relation.referenceStevens SM, 2016, J THROMB THROMBOLYS, V41, P154, DOI 10.1007/s11239-015-1316-1eng
hcfmusp.relation.referenceStrakhan M, 2014, CASE REP HEMATOL, V2014, DOI 10.1155/2014/704371eng
hcfmusp.relation.referenceSule G, 2020, ARTHRITIS RHEUMATOL, V72, P114, DOI 10.1002/art.41057eng
hcfmusp.relation.referenceTaylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5eng
hcfmusp.relation.referenceTektonidou MG, 2019, RMD OPEN, V5, DOI 10.1136/rmdopen-2019-000924eng
hcfmusp.relation.referenceTektonidou MG, 2019, ANN RHEUM DIS, V78, P1296, DOI 10.1136/annrheumdis-2019-215213eng
hcfmusp.relation.referenceTektonidou MG, 2009, ARTHRIT RHEUM-ARTHR, V61, P29, DOI 10.1002/art.24232eng
hcfmusp.relation.referenceten Boekel E, 2002, PATHOPHYSIOL HAEMO T, V32, P137, DOI 10.1159/000065217eng
hcfmusp.relation.referenceTripodi A, 2020, J THROMB HAEMOST, V18, P1569, DOI 10.1111/jth.14846eng
hcfmusp.relation.referencevan Es N, 2014, BLOOD, V124, P1968, DOI [10.1182/blood-2014-04-571232, 10.1182/blood-2014-04571232]eng
hcfmusp.relation.referenceVerro P, 1998, STROKE, V29, P2245, DOI 10.1161/01.STR.29.11.2245eng
hcfmusp.relation.referenceWang Chrong-Reen, 2017, Semin Arthritis Rheum, V47, pe7, DOI 10.1016/j.semarthrit.2017.03.012eng
hcfmusp.relation.referenceWhitlock EP, 2016, ANN INTERN MED, V164, P826, DOI 10.7326/M15-2112eng
hcfmusp.relation.referenceWillis R, 2011, AUTOIMMUN HIGHLIGHTS, V2, P35, DOI 10.1007/s13317-011-0017-9eng
hcfmusp.relation.referenceWillis R, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-014-0485-9eng
hcfmusp.relation.referenceWoller SC, 2018, CLIN APPL THROMB-HEM, V24, P192, DOI 10.1177/1076029617729214eng
hcfmusp.relation.referenceWoller SC, 2016, CLIN APPL THROMB-HEM, V22, P239, DOI 10.1177/1076029615615960eng
hcfmusp.relation.referenceXourgia E, 2019, J AUTOIMMUN, V104, DOI 10.1016/j.jaut.2019.102311eng
hcfmusp.relation.referenceYachoui R, 2015, SEMIN ARTHRITIS RHEU, V44, P652, DOI 10.1016/j.semarthrit.2014.10.013eng
hcfmusp.relation.referenceYadav V, 2019, J CLIN INVEST, V129, P2872, DOI 10.1172/JCI124804eng
hcfmusp.relation.referenceYalavarthi S, 2015, ARTHRITIS RHEUMATOL, V67, P2990, DOI 10.1002/art.39247eng
hcfmusp.relation.referenceYazici A, 2017, LUPUS, V26, P1123, DOI 10.1177/0961203316682102eng
hcfmusp.relation.referenceZhou H, 2004, BLOOD, V104, P2353, DOI 10.1182/blood-2004-01-0145eng
hcfmusp.relation.referenceZikos TA, 2015, JCR-J CLIN RHEUMATOL, V21, P311, DOI 10.1097/RHU.0000000000000290eng
hcfmusp.relation.referenceZuo Y, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0775-8eng
hcfmusp.relation.reference2004, JAMA, V291, P576eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication89219896-6125-4035-9e68-08da2f4a54c1
relation.isAuthorOfPublication.latestForDiscovery89219896-6125-4035-9e68-08da2f4a54c1
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
art_COHEN_16th_International_Congress_on_Antiphospholipid_Antibodies_Task_Force_2020.PDF
Tamanho:
759.48 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/17
Artigos e Materiais de Revistas Científicas - ODS/03